The Jackson Laboratory:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:The Jackson Laboratory - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C7553
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:54
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥34,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥69,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥103,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
The Jackson Laboratory (JAX) is a biomedical research center that offers clinical genomic solutions. The center provides breeding and rederivation services. It offers cryopreservation and recovery services such as sperm cryopreservation, on-site sperm cryopreservation, embryo cryopreservation, cryo storage, cryorecovery and sponsored strain distribution. Jax provides various surgical procedures including hysterectomy, ovariectomy, vasectomy, jejunum catheterization, microchip insertion, brain cannulation, cholecystectomy, and others. The center also offers in vivo pharmacology services for basic research and therapeutic development to the fields of oncology, immunology, metabolic diseases, rare diseases and neurobiology. It has operations in Maine, Connecticut and California, the US. JAX is headquartered in Bar Harbor, Maine, the US.

The Jackson Laboratory – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
The Jackson Laboratory, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
The Jackson Laboratory, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
The Jackson Laboratory, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
The Jackson Laboratory, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
The Jackson Laboratory, Medical Devices Deals, 2012 to YTD 2018 10
The Jackson Laboratory, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
The Jackson Laboratory, Pharmaceuticals & Healthcare, Deal Details 12
Partnerships 12
Crown Bioscience and Jackson Lab Enter into Agreement 12
Jackson Labs Entered into Research Agreement with Wenzhou Municipal People’s Government, Ouhai District People’s Government and Wenzhou Medical University 13
Jackson Labs and University of Connecticut Form Joint Venture 14
Jackson Lab Enters into Co-Development Agreement with Beth Israel Deaconess Medical Center 15
CollabRx Enters Into Agreement With Jackson Labs 16
Jackson Labs Enters Into Research Agreement With Hartford Hospital And Connecticut Children’s Medical Care For Cancer Treatment 17
Licensing Agreements 19
Jackson Laboratory Enters into Licensing Agreement with Caribou Biosciences 19
Cyteir Therapeutics Enters into Licensing Agreement with Jackson Laboratory 20
The Jackson Laboratory – Key Competitors 21
The Jackson Laboratory – Key Employees 22
The Jackson Laboratory – Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Recent Developments 25
Government and Public Interest 25
Sep 27, 2018: Probing the genetics of islet stress and resilience in type 2 diabetes 25
Sep 13, 2018: JAX, Azitra receive Department of Defense grant: Bioengineered commensals to fight Staphylococcus aureus 26
Sep 13, 2018: The Jackson Laboratory and Azitra receive Department of Defense Grant: Bioengineered Commensals to fight Staphylococcus Aureus 27
Sep 05, 2018: A better combination therapy for leukemias 28
Sep 04, 2018: Using mathematical modeling to target infections 29
Aug 01, 2018: $2m NIH grant to study genetic mechanisms of inherited heart muscle disorders 30
Jul 12, 2018: New Research Effort to Understand Role of Apoe Mutation in Alzheimer’s Disease 31
Jun 26, 2018: JAX receives $1.5 million for glaucoma research 32
Apr 19, 2018: Jackson Laboratory Researchers Awarded Grant From Chan Zuckerberg Initiative 33
Feb 05, 2018: American Diabetes Association Awards $9.75 million to Six Leading Researchers for the 2018 Pathway to Stop Diabetes® Research Grants 34
Jan 09, 2018: $3.2 Million Grant To Jax Scientist For Epigenetic Studies To Advance Precision Medicine 36
Dec 17, 2017: New Information Standard Announced For PDX Models To Improve Cancer Research 37
Dec 01, 2017: Better vaccine targeting: study identifies key mechanism 38
Oct 02, 2017: TSRI Researchers Join National Digital Health Informatics Collaborative 39
Sep 27, 2017: NIH Awards $10.6M Research Center Grant To The Jackson Laboratory For Study Of Chronic Fatigue Syndrome 40
Sep 18, 2017: New $5.4M grant funds JAX studies of ‘cognitive resilience’ to Alzheimer’s disease 41
Sep 10, 2017: $2.1M National Eye Institute grant funds JAX research in inherited retinal diseases 42
Aug 20, 2017: Jax Receives $2M Federal Grant to Study Role of RNA Structure In Gene Regulation 43
Aug 15, 2017: New $1.9M federal grant to fund JAX studies of microbiome’s role in multiple sclerosis 44
Aug 14, 2017: $2.3M in federal funding to JAX to support studies of aging immune system 45
May 14, 2017: New $2.7M Federal Grant Awarded To Jax Alzheimer’s Researcher 46
May 14, 2017: New $3.2M federal grant awarded to JAX Alzheimers researcher 47
Mar 02, 2017: $2.8 million in federal grants to JAX scientists to target triple-negative breast cancers 48
Mar 01, 2017: JAX receives NIH grant to improve CRISPR-Cas9 accuracy 50
Mar 01, 2017: JAX Receives Federal Grant To Improve CRISPR-Cas9 Accuracy, Efficiency And Reliability 51
Feb 03, 2017: JAX receives $6.7 million federal research grant to create 3-D genome map 52
Other Significant Developments 53
Jul 22, 2018: Eight new mouse models for Alzheimer’s disease available to researchers 53
Appendix 54
Methodology 54
About GlobalData 54
Contact Us 54
Disclaimer 54

List of Tables
The Jackson Laboratory, Pharmaceuticals & Healthcare, Key Facts 2
The Jackson Laboratory, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
The Jackson Laboratory, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
The Jackson Laboratory, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
The Jackson Laboratory, Deals By Therapy Area, 2012 to YTD 2018 9
The Jackson Laboratory, Medical Devices Deals, 2012 to YTD 2018 10
The Jackson Laboratory, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Crown Bioscience and Jackson Lab Enter into Agreement 12
Jackson Labs Entered into Research Agreement with Wenzhou Municipal People's Government, Ouhai District People's Government and Wenzhou Medical University 13
Jackson Labs and University of Connecticut Form Joint Venture 14
Jackson Lab Enters into Co-Development Agreement with Beth Israel Deaconess Medical Center 15
CollabRx Enters Into Agreement With Jackson Labs 16
Jackson Labs Enters Into Research Agreement With Hartford Hospital And Connecticut Children's Medical Care For Cancer Treatment 17
Jackson Laboratory Enters into Licensing Agreement with Caribou Biosciences 19
Cyteir Therapeutics Enters into Licensing Agreement with Jackson Laboratory 20
The Jackson Laboratory, Key Competitors 21
The Jackson Laboratory, Key Employees 22
The Jackson Laboratory, Other Locations 24

List of Figures
The Jackson Laboratory, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
The Jackson Laboratory, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
The Jackson Laboratory, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
The Jackson Laboratory, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
The Jackson Laboratory, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
The Jackson Laboratory, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
The Jackson Laboratory, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
The Jackson Laboratory, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
The Jackson Laboratory, Medical Devices Deals, 2012 to YTD 2018 10

★海外企業調査レポート[The Jackson Laboratory:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Hongkong Land Holdings Ltd:企業の戦略・SWOT・財務分析
    Hongkong Land Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Hongkong Land Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Novus Therapeutics Inc (NVUS):製薬・医療:M&Aディール及び事業提携情報
    Summary Novus Therapeutics Inc (Tokai Pharma), formerly Tokai Pharmaceuticals Inc is a pharmaceutical company that develops products for ear, nose and throat. The company’s lead products is a nasally-administer, combination drug product and eustachian tube dysfunction, among others. Its galeterone i …
  • Allegion Plc:企業の戦略・SWOT・財務情報
    Allegion Plc - Strategy, SWOT and Corporate Finance Report Summary Allegion Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Antero Resources Corp Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Antero Resources Corp Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Antero Resources Corp (Antero) is an independent oil and natural gas company that explores, develops, produces and sells natural gas and oil from the Appalachia Basin. It gather and process wel …
  • Venator Materials PLC (VNTR):企業の財務・戦略的SWOT分析
    Venator Materials PLC (VNTR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • MiMedx Group Inc (MDXG)-医療機器分野:企業M&A・提携分析
    Summary MiMedx Group Inc (MiMedx) is a provider of bioactive healing products for tissue regeneration. The company’s products are used in the therapeutic areas of chronic wounds, dental, ophthalmology, spine, orthopedic surgery, sports medicine and urology. Its products help in reducing inflammation …
  • Reebok International Ltd.:企業の戦略・SWOT・財務情報
    Reebok International Ltd. - Strategy, SWOT and Corporate Finance Report Summary Reebok International Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Isto Biologics:医療機器:M&Aディール及び事業提携情報
    Summary Isto Biologics is an orthobiologics company which manufactures and develops biological products to treat orthopedic and spine disorders. The company offers solutions in cell therapy, bone healing and regeneration that harness cells and proteins naturally found in human biology which support …
  • Kering SA:企業の戦略・SWOT・財務情報
    Kering SA - Strategy, SWOT and Corporate Finance Report Summary Kering SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Darling Ingredients Inc.:企業のM&A・事業提携・投資動向
    Darling Ingredients Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Darling Ingredients Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • Novaliq GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary Novaliq GmbH (Novaliq) is a drug delivery company that develops pharmaceutical formulations. The company develops dermatological products, novel ophthalmic, and solutions for organ preservation based on the physicochemical properties of semifluorinated alkanes. It offers NovaTears a preserva …
  • Philex Mining Corp:企業の戦略・SWOT・財務情報
    Philex Mining Corp - Strategy, SWOT and Corporate Finance Report Summary Philex Mining Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Takara Bio Inc (4974):企業の財務・戦略的SWOT分析
    Summary Takara Bio Inc (Takara), a subsidiary of Takara Holdings Inc, is a biotechnology company that develops, manufactures and distributes biotechnology research reagents and equipments for life sciences research. The company sells gene amplification system and offers scientific instruments. It of …
  • Filtration Group Corporation:企業の戦略的SWOT分析
    Filtration Group Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Micron Technology Inc:企業の戦略・SWOT・財務情報
    Micron Technology Inc - Strategy, SWOT and Corporate Finance Report Summary Micron Technology Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • ASIT Biotech SA (ASIT):企業の財務・戦略的SWOT分析
    Summary ASIT Biotech SA (ASIT Biotech), formerly BioTech Tools SA is a clinical stage biopharmaceutical company that develops in-vitro and in-vivo biotech tools. The company develops and commercializes immunotherapy medicines for respiratory and food allergies using ASIT plus technology platform. It …
  • Verizon Connect:企業の戦略的SWOT分析
    Verizon Connect - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Eutelsat Communications S.A. (ETL):企業の財務・戦略的SWOT分析
    Eutelsat Communications S.A. (ETL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Dairyland Power Cooperative:企業の戦略的SWOT分析
    Dairyland Power Cooperative - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • BJ’s Restaurants, Inc.:企業の戦略・SWOT・財務情報
    BJ's Restaurants, Inc. - Strategy, SWOT and Corporate Finance Report Summary BJ's Restaurants, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆